[1]
Luo, J. et al. 2024. ACTR10 Overexpression Facilitates the Progression and Tyrosine Kinase Inhibitor Resistance in Hepatocellular Carcinoma. World Journal of Oncology. 15, 6 (Dec. 2024), 882–901. DOI:https://doi.org/10.14740/wjon1944.